Company's CEO Acquires Shares in Oncopeptides
Stockholm, Sweden - Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that the company's CEO, Jakob Lindberg acquired 45,000 shares in Oncopeptides for a value of SEK 1.9M in addition to the shares that he subscribed for in the recent share issue in connection with the IPO.For further information, please contact:Jakob Lindberg, CEO at OncopeptidesE-mail: jakob.lindberg@oncopeptides.seRein Piir, Head of Investor Relations at OncopeptidesE-mail: rein.piir@oncopeptides.se Mobil: +46 708537292This information is information that Oncopeptides is obliged to disclose pursuant to